SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Enphases IQ SST solid-state transformer development for AI data-center power is drawing attention, with traders highlighting Texas production progress and planned demonstrations and customer pilots. Bulls see a potential growth avenue beyond residential solar and expect a rebound or short squeeze, while skeptics point to higher rates, weak solar demand and uncertainty about how quickly the opportunity could translate into revenue.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Oppenheimers upgrade of Fastly, citing larger contracts and early monetization of agentic-AI traffic, is driving attention. Bulls see AI and security demand as growth drivers, while skeptics question how much the traffic will translate into revenue before the next earnings report.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckins share buyback and the prospect of a U.S. exchange relisting dominate discussion, alongside the companys Mubadala-backed strategic investment and possible Middle East expansion. Bulls see institutional backing, international growth and continued store expansion as long-term positives, while others point to the stocks persistent range-bound trading, weak price action and lingering governance concerns; relisting timing remains speculative.

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Abivax - ADR

Abivaxs sharp pullback and the absence of a confirmed takeover dominate discussion, with traders split between expecting a Big Pharma bid and viewing the stock as potentially stalled while the company advances obefazimod toward an ulcerative-colitis filing and Crohns data. A French filing reportedly showing Helikon increased its stake also drew attention, but takeover speculation remains unconfirmed.

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis Corp 

A DEA administrative-law pause in the broader cannabis rescheduling process, prompted by questions about federal review procedures, has driven debate and volatility in cannabis stocks. Traders disagree over whether the pause is a temporary procedural delay or a setback to Schedule III and related tax relief; some see Trulieves medical-cannabis exposure as cushioning the impact, while others note it sold off with the sector.

KraneShares Trust - KraneShares CSI China Internet ETF

KraneShares CSI China Internet ETF

A modest rebound in Chinese internet stocks has revived discussion of a possible oversold bounce and rotation into China tech, with traders pointing to support and bullish options activity. Others argue the ETF remains in a broader downtrend, citing China-market weakness, policy risks, and persistent underperformance; no single confirmed catalyst dominates.

Rubrik, Inc. engages in the provision of cloud data management solutions. Its solutions include backup and recovery, VM backup, Microsoft 365, ransom ware recovery, database backup, cloud solutions, and Polaris sonar. Rubrik products include data protection, data threat analytics, data security posture and cyber recovery. The company was founded by Bipul Sinha, Arvind Jain, Soham Mazumdar, and Arvind Nithrakashyap in December 2013 and is headquartered in Palo Alto, CA.

Rubrik Inc. - Ordinary Shares - Class A

Rubrik Inc. - Class A

Rubriks rally to fresh highs and strength above key resistance are driving attention, with bulls citing continued momentum and cybersecurity demand while bears warn of valuation risk, insider selling, and relative underperformance versus cybersecurity peers. Traders are also debating whether to hold for further gains or take profits after the sharp run-up.

Arista Networks, Inc. engages in the development, marketing, and sale of cloud networking solutions. Its solutions include EOS, a set of network applications, and Gigabit Ethernet switching and routing platforms. Its product categories include core, cognitive adjacencies, and cognitive networks. The company was founded by Andreas Bechtolsheim, David Cheriton, and Kenneth Duda in November 2004 and is headquartered in Santa Clara, CA.

Arista Networks Inc

Arista shares are drawing attention after breaking to fresh 52-week and all-time highs, with traders framing the move as a breakout. Many are bullish on demand for AI data-center networking and recent analyst optimism, while others caution about profit-taking, insider sales, and choppy price action.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Traders are focused on COMPs potential technical breakout, pointing to bull-flag and consolidation patterns and its capped supply as reasons for optimism. Others remain skeptical, citing weak follow-through and underperformance versus other crypto assets.

Select Sector SPDR Trust (The) - State Street Technology Select Sector SPDR ETF

Technology Select Sector SPDR Fund

Technology-sector leadership, supported by optimism around AI and semiconductor demand, is the main focus, with traders pointing to XLKs strong momentum and breakout potential. Others caution that techs gains are concentrated in a few large companies, leaving weak market breadth and the possibility of rotation or a pullback as counterpoints.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Addex Therapeutics H1 Net Loss Widens, Operating Loss Narrows; Advances GABAB PAM Cough Program

(RTTNews) - Addex Therapeutics Ltd. (ADXN, ADXN.SW) on Monday reported a wider net loss for the first half, while operating loss narrowed from last year on lower research and development expenses...

Addex Therapeutics Reports Q1 2026 Results: Full Earnings Call Transcript

Addex Therapeutics (NASDAQ:ADXN) reported first-quarter financial results on Thursday. The transcript from the company's first-quarter earnings call has been provided below.
Benzinga APIs provide real-time access toread more...

Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. Its pipeline includes Dipraglurant, ADX71149, GABAB PAM, mGlu7 NAM, mGlu2 NAM, mGlu4 PAM, and mGlu3 PAM. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.

Addex Therapeutics Ltd - ADR

Bullish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Stocktwits

Stocktwits Polls

$ADXN Addex Therapeutics announced at 1:00 a.m. Eastern today that its spin-out company, Neurosterix, has completed Phase 1 clinical studies of NTX-253 for schizophrenia and plans to advance the drug into Phase 2 clinical development. This is a genuinely new development since our previous check.

Mike Teve

$ADXN not the companies fault.  Its all these dopes that convince you small caps have value and arent just trades.  It’s them.  It’s the furu’s selling services.  They are the devil.  The companies are all the same. Fundraisers of various capacities.

Chart Symphony

$ADXN the company did a stock offering and they have enough money until the second quarter of next year so they're not going to delist or split or anything like that

Feed

News

Sentiment

Earnings

Fundamentals

Info

ADXN Addex Therapeutics Ltd - ADR

Fundamentals

Latest ADXN News